Related Experiment Video
Updated: May 16, 2026

Expansion of Human Peripheral Blood γδ T Cells using Zoledronate
Published on: September 9, 2011
Drug-induced dermatomyositis after zoledronic acid
Philip L Tong1, Lawrence L Yu, Jonathan J Chan
1Department of Dermatology, Sir Charles Gairdner Hospital Dermatopathology WA School of Pathology and Laboratory Medicine, University of Western Australia, Perth, WA 6009, Australia. philipleitong@gmail.com
Abstract:
A 57-year-old woman with prior exposure to bisphosphonates developed myalgia, proximal muscle weakness and lichenoid rash over the upper extremities and face 3 days after infusion of zoledronic acid for the management of osteoporosis. The diagnosis of dermatomyositis was made on the basis of clinical, laboratory and histological findings. This is the first report of drug-induced dermatomyositis secondary to zoledronic acid.
Related Concept Videos
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
The binding of dantrolene to the RYR1...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Drug toxicity: Idiosyncratic Reactions
Myocarditis III: Medical Management
Drug Toxicity: Allergic Reactions
Myocarditis I: Introduction
